Communication is Key in Complex Tech Transfer

tadamichi - Stock.adobe.com

The relationship between pharmaceutical companies and the contract organizations that perform development and manufacturing services comes with the necessary process of transferring intellectual information, processes, and product from one organization to another. Complex products such as biologics and messenger RNA (mRNA) vaccines come with additional challenges during the tech transfer process.

To gain more insight on the complexities of transfer of pharmaceutical technology between contractors and sponsors, Pharmaceutical Technology® spoke with Petra Dieterich, scientific leader, and Jeffrey Mocny, scientific leader-Early Development, both with Abzena; Peter Ercoli, chief operating officer, Biologics, at BIOVECTRA; Deepak Thassu, PhD, MBA, senior vice president, R&D and Regulatory Submission, at LGM Pharma; Emma Rhodes, head of New Product Introduction at Sterling Pharma Solutions; Sara Schemel, senior process engineer, Dona York, principal process engineer, and Gauri Patki, senior process engineer, all at Catalent Biologics; Uwe Hanenberg, PhD, head of Product Development at Recipharm; and Rebecca Powell, associate director, Tech Transfer at Arranta Bio, a Recipharm company.

About the author

Susan Haigney is managing editor for BioPharm International.

Article details

BioPharm International
eBook: Partnerships for Outsourcing
May 2023
Pages: 32–37

Citation

When referring to this article, please cite it as Haigney, S. Communication is Key in Complex Tech Transfer. BioPharm International, Partnerships for Outsourcing eBook May 2023.